All News #Library
Biotech
Ber Gen Bio and Oncoinvent Propose Merger and Rights Issue
30 Jun 2025 //
PR NEWSWIRE
BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC
06 Nov 2023 //
PR NEWSWIRE
BerGenBio Announces First Patient Dosed in Ph1b/2a Trial Evaluating Bemcentinib
09 Mar 2023 //
PR NEWSWIRE
BerGenBio Announces Positive Data From Phase 2 of Bemcentinib with Pembrolizumab
15 Feb 2023 //
PR NEWSWIRE

Market Place
Sourcing Support